The government-funded COVID-19 vaccination program is from Jan. 1 to Feb. 28 next year to be expanded to cover all residents ...

Novavax (NASDAQ: NVAX) was once a leading contender to dominate the coronavirus vaccine market. The company faced several ...

The agency claimed that 10 children’s deaths were linked to the shots, although it did not release evidence to support the ...

FDA widens its Covid vaccine safety review as HHS Secretary Robert F. Kennedy Jr. questions longstanding guidance and companies defend their records.

Physician and science communicator Kristen Panthagani talks about why public trust in vaccines has fallen since the COVID-19 ...

A fresh study authored by CDC scientists is throwing water on the argument that children do not need the COVID-19 vaccine. Investigators examined electronic health records in nine states of emergency ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...

The FDA vaccine approval road map proposes longer trials and stricter evidence to improve vaccine safety and effectiveness oversight.

With the help of artificial intelligence, an international team of researchers has made the first major inroad to date toward ...

Upending decades-old guidance, the Centers for Disease Control and Prevention’s vaccine advisory committee voted to no longer ...

After weakening an endorsement for the hepatitis B vaccine, ACIP began debating the merits of the protocol used to inoculate ...

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid.